sales@angenesci.com
Login | Register
logo
Structures Search
Home Sulfos 1-Naphthalenesulfonamide, N-[[trans-4-[[(4-amino-2-quinazolinyl)amino]methyl]cyclohexyl]methyl]-, hydrochloride (1:1)

1-Naphthalenesulfonamide, N-[[trans-4-[[(4-amino-2-quinazolinyl)amino]methyl]cyclohexyl]methyl]-, hydrochloride (1:1)

CAS No.:
192322-50-2
Catalog Number:
AG002FTZ
Molecular Formula:
C26H30ClN5O2S
Molecular Weight:
512.0667
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
99%
1 week
United States
$223
- +
10mg
99%
1 week
United States
$307
- +
50mg
99%
1 week
United States
$1057
- +
100mg
99%
1 week
United States
$1793
- +
Product Description
Catalog Number:
AG002FTZ
Chemical Name:
1-Naphthalenesulfonamide, N-[[trans-4-[[(4-amino-2-quinazolinyl)amino]methyl]cyclohexyl]methyl]-, hydrochloride (1:1)
CAS Number:
192322-50-2
Molecular Formula:
C26H30ClN5O2S
Molecular Weight:
512.0667
MDL Number:
MFCD07783999
IUPAC Name:
N-[[4-[[(4-aminoquinazolin-2-yl)amino]methyl]cyclohexyl]methyl]naphthalene-1-sulfonamide;hydrochloride
InChI:
InChI=1S/C26H29N5O2S.ClH/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24;/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31);1H
InChI Key:
DIQDKUNCSVFGHH-UHFFFAOYSA-N
SMILES:
Nc1nc(NC[C@@H]2CC[C@H](CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2.Cl
UNII:
45B73P82A3
Properties
Complexity:
751  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
511.181g/mol
Formal Charge:
0
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
512.069g/mol
Monoisotopic Mass:
511.181g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
118A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Molecular cancer research : MCR 20100401
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors. Neuropharmacology 20070501
Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A. Archiv der Pharmazie 20031201
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. British journal of pharmacology 20030801
Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010101
Properties